Investors

Shaping together the future
of medical imaging

Thanks to the continued support of its investors,
Intrasense has expanded its portfolio and
business activities to address new markets
in France and worldwide.

We are ambitious. We are passionate.
We believe in the future through innovation.

News & strategies

Let us share
our strategic directions.

We have identified major opportunities opening up for new applications of Myrian® innovative technologies in the fields of health information systems, artificial intelligence and deep-learning.

Let’s share our road map >

Read our latest news >

Learn more about the proposed transaction with DMS-Group (French) >

Receive our news by email >

Financial documentation

Let's read
our latest publications.

Accounts & reports >

Regulated information >

General meetings >

OCABSA >

If you cannot find the information you are looking for,
please do not hesitate to contact us.

Agenda

> 18/07/03 - Paris: Shareholder meeting - Strategy and projects
> See presentation
> Read FAQ >
> General meeting postponed >: date to come

Stock market data

Identification

Name: Intrasense
Ticker symbol
: ALINS
ISIN code : FR0011179886
Bloomberg : ALINS:FP
Reuters : ALINS.PA
Number of shares : 15,612,878

Capital distribution

Analyst coverage

AURGALYS - Galina Sotnikova (18/05/23)
Download the document
AURGALYS - Galina Sotnikova (18/05/02)
Download the document
AURGALYS - Galina Sotnikova (18/03/22)
Download the document
AURGALYS - Mickael Dubourd (17/02/15)
Download the document

Investors contact

Intrasense

Nicolas Reymond
CEO
1231 avenue du Mondial 98
34000 MONTPELLIER | FRANCE
Email : investor@intrasense.fr

Newcap

Valentine Brouchot & Pierre Laurent
Financial communications
and investor relations
Tel : +33 (0)1 44 71 94 96
Email : intrasense@newcap.eu

Intrasense_blanc

GMED_ISO

map_20161028

Contact
LinkedIn
YouTube
Twitter
Viadeo
WeChat

Headquarters / Siège social :
1231, avenue du Mondial 98
34000 MONTPELLIER | FRANCE